Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001485003-16-000044)

Filing Details

Accession Number:: 0001485003-16-000044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-17 17:04:28
Reporting Period:: 2016-02-16

Filing Date:: 2016-02-17
Accepted Time:: 2016-02-17 17:04:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1485003	Eleven Biotherapeutics Inc.	EBIO	Pharmaceutical Preparations (2834)	252025616

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1205535	J John Mccabe	C/O Eleven Biotherapeutics, Inc. 215 First Street, Suite 400 Cambridge MA 02142	Senior Vice President, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-02-16	1,501	$0.27	8,499	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.